Effects of sumatriptan nasal: A Synthesis of Findings from 28 Studies
- Home
- Effects of sumatriptan nasal
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of sumatriptan nasal: A Synthesis of Findings from 28 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main Research Findings
Several studies have shown that sumatriptan nasal spray may be an effective treatment for migraine and cluster headache. 25 found that intranasal sumatriptan was significantly more effective than placebo in a randomized, placebo-controlled, double-blind study of cluster headache patients. 23 demonstrated the effectiveness of nasal sumatriptan in treating migraine attacks in children and adolescents. Additionally, 11 showed that intranasal sumatriptan had a faster onset of action and a similar sustained effect compared to oral sumatriptan. These findings suggest that sumatriptan nasal spray may be a viable treatment option for acute migraine and cluster headache.
However, the effectiveness of sumatriptan nasal spray has not been confirmed for all patients. 2 found that sumatriptan nasal spray was less effective than subcutaneous injection in treating cluster headache patients in an open-label study. Furthermore, 6 identified factors like young age of onset, psychiatric disorders, and headache location as potential indicators of a negative response to sumatriptan nasal spray.
Benefits and Risks
Benefits Summary
Sumatriptan nasal spray may be a useful treatment option for acute migraine and cluster headache. It may be especially beneficial for patients who find oral administration challenging or those seeking a faster onset of action. 7 found that sumatriptan nasal spray is absorbed more quickly and has a faster onset of action compared to conventional nasal sprays. 26 showed that sumatriptan nasal spray is safe when used in combination with other medications.
Risk Summary
There are some risks associated with using sumatriptan nasal spray. The most common side effects are nasal discomfort and taste disturbances. 7 found that sumatriptan nasal spray is generally well-tolerated, with only a few reported cases of discontinuation due to side effects. However, 21 suggests that long-term use of sumatriptan nasal spray may lead to tolerance in some patients. Also, sumatriptan nasal spray should not be used by people with pre-existing conditions like heart disease or high blood pressure. 20 states that sumatriptan nasal spray is contraindicated in patients with heart disease or high blood pressure. Additionally, sumatriptan nasal spray is not recommended for pregnant or breastfeeding women.
Comparison Across Studies
Similarities Across Studies
Multiple studies suggest that sumatriptan nasal spray may be effective in treating acute migraine and cluster headache. Many studies also show that sumatriptan nasal spray is generally safe and well-tolerated.
Differences Across Studies
Some studies have shown that the effectiveness of sumatriptan nasal spray can vary depending on the patient and the type of headache. 2 found that sumatriptan nasal spray was less effective than subcutaneous injection in treating cluster headache patients. In contrast, 23 showed that sumatriptan nasal spray was effective in treating migraine attacks in children and adolescents. These findings suggest that the effectiveness of sumatriptan nasal spray might vary depending on the patient and the type of headache.
Consistency and Inconsistencies in the Results
While multiple studies suggest that sumatriptan nasal spray may be effective in treating acute migraine and cluster headache, the effectiveness hasn’t been confirmed in all studies. 2 found that sumatriptan nasal spray was less effective than subcutaneous injection in treating cluster headache patients in an open-label study. This finding contradicts some other findings. Further research is needed to clarify the inconsistencies and address these contradictions.
Considerations for Real-World Application
Sumatriptan nasal spray may be a beneficial treatment option for acute migraine and cluster headache, but its effectiveness might vary between patients. Sumatriptan nasal spray has associated risks. It’s important to discuss with your doctor and explore all treatment options to choose the best one for your needs. 10 found that sumatriptan nasal spray is not recommended for treating migraine in children.
Limitations of Current Research
There is still a need for further research on the effectiveness of sumatriptan nasal spray. Specifically, more research is needed to understand the safety of sumatriptan nasal spray in children and pregnant women. Additional research is also needed to evaluate the long-term effects of sumatriptan nasal spray and ways to improve its efficacy.
Future Research Directions
Further research is necessary to address the remaining questions regarding the effectiveness of sumatriptan nasal spray. Research focusing on the safety of sumatriptan nasal spray in children and pregnant women, the long-term effects of sumatriptan nasal spray, and ways to enhance its efficacy are essential for optimizing the use of this medication.
Conclusion
Sumatriptan nasal spray may be a valuable treatment option for acute migraine and cluster headache. However, there are some risks associated with its use. It is important to discuss with your doctor and choose the most appropriate treatment option. Further research is necessary to better understand the effectiveness and safety of sumatriptan nasal spray.
Benefit Keywords
Risk Keywords
Article Type
Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine.
Author: DiamondS, ElkindA, JacksonR T, RyanR, DeBusseyS, AsgharnejadM
Language : English
Author: HardeboJ E, DahlöfC
Language : English
Language : English
Author: ChengLi-Hsiang, WuPei-Chuan, LiuShao-Cheng, ChiuFeng-Shiang, ChuYueng-Hsiang, ChangYing-Nan, WangHsing-Won
Language : English
Author: ChanchlaniRoshan, AgrawalAmit, JanjuaDalwinder, HafsaShaik Nida
Language : English
Author: IshiiMasakazu, KatohHirotaka, ImawakaMotoaki, KasaiHideyo, IshibashiMasaaki
Language : Japanese
Author: SilbersteinStephen D
Language : English
Author: SilbersteinStephen
Language : English
Author: SilbersteinStephen, WinnerPaul K, McAllisterPeter J, TepperStewart J, HalkerRashmi, MahmoudRamy A, SiffertJoao
Language : English
Author: PatniyotIrene R, GelfandAmy A
Language : English
Author: TepperStewart J, CadyRoger K, SilbersteinStephen, MessinaJohn, MahmoudRamy A, DjupeslandPer G, ShinPaul, SiffertJoao
Language : English
Author: Wöber-BingölÇiçek
Language : English
Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized study.
Author: FraserIain P, HanLingling, HanTae H, LiChi-Chung, HreniukDavid, StochS Aubrey, WagnerJohn A, LinderSteven, WinnerPaul
Language : English
Author: DjupeslandP G, DocekalP,
Language : English
Author: BigalMarcelo, RapoportAlan, AuroraSheena, SheftellFred, TepperStewart, DahlofCarl
Language : English
Author: WinnerPaul, RothnerA David, WootenJohn D, WebsterChris, AmesMichael
Language : English
Author: McCroryP, HeywoodJ, UgoniA
Language : English
Author: CuvellierJ C, JoriotS, AuvinS, ValléeL
Language : French
Author: JuhaszG, ZsombokT, JakabB, NemethJ, SzolcsanyiJ, BagdyG
Language : English
Author: TorelliP, ManzoniG C
Language : English
Author: NatarajanShankar, JabbourJ T, WebsterChristopher J, RichardsonMary S
Language : English
Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
Author: SheftellFred D, FeleppaMichele, TepperStewart J, VolcyMichel, RapoportAlan M, BigalMarcelo E
Language : English
Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial.
Author: AhonenKati, HämäläinenMirja L, RantalaHeikki, HoppuKalle
Language : English
Author: PakalnisAnn, KringDonna, PaolicchiJuliann
Language : English
Author: van VlietJ A, BahraA, MartinV, RamadanN, AuroraS K, MathewN T, FerrariM D, GoadsbyP J
Language : English
Author: VachharajaniN N, ShyuW-C, NicholaP S, BoultonD W
Language : English
Author: Schuh-HoferSigrid, ReuterUwe, KinzeStephan, EinhäuplKarl Max, ArnoldGuy
Language : English
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.